Ambar Bhattacharyya is a vice president in BVP’s Cambridge, MA office. His past investments include successful exits in many market-leading companies, including LinkedIn (IPO), Verastem (IPO), OvaScience (IPO), Liazon (acq’d), Accelecare (acq’d), iPay Technologies (acq’d), and VMLogix (acq’d). Today, he focuses on investments in early- and growth-stage companies in the healthcare, education, and technology sectors and is highly involved in Bessemer's current investments in DocuTAP, Health Essentials, Instructure, Fractyl Laboratories, and Accuvein.
Prior to joining Bessemer, Ambar worked as an associate at Bain Capital Ventures in the healthcare and technology practices. Before Bain Capital, Ambar was the assistant to the CEO at MinuteClinic, a company that runs health clinics staffed by nurse practitioners inside retail settings and was acquired by CVS. He began his career at Bain & Co. where he worked on projects across various industries, including healthcare, business services and technology, as well as for non-profit clients at The Bridgespan Group. After attending business school, Ambar worked with with the City of Fremont, CA, where he helped the city develop its clean-tech strategy.
Ambar holds an MBA with distinction from Harvard Business School and a B.S. in economics and a B.A. in psychology from the University of Pennsylvania, where he graduated magna cum laude. He currently is the co-Chair of New England Venture Network (NEVN). Ambar also serves on the boards of UP Academy of Boston and Dorchester, two in-district turnaround charter schools in the greater Boston area. In 2012, he was selected by the World Economic Forum as a Global Shaper, a group of leaders under the age of 30 charged with catalyzing positive social change in their respective communities. Ambar regularly blogs at HCVC's with BVP's Steve Kraus.